Clinical Trials Browser

INDUSTRY × Carcinoma, Renal Cell × trebananib × Clear all

NCT00467025 2016-03-23

AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib

Phase 2 Completed

Carcinoma, Renal Cell